Name | Title | Contact Details |
---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Kern Medical Center is a Bakersfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Physicians Programs Inc is a Flint, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Consult-Pro is a East York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Peregrine Pharmaceuticals, Inc. (Peregrine) is a clinical-stage biopharmaceutical company that manufactures and develops monoclonal antibodies for the treatment of cancer and viral infections.